Several CIs have been extensively studied in BC, mainly including programmed cell death protein 1 (PD-1), programmed death-ligand 1 (PD-L1), cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4), and lymphocyte-activation gene 3 (LAG-3) [168]. This evidence concerns the gene LAG3 and breast cancer.